title: Prostate cancer in 2014: The year chemotherapy finally gets some respect!
authors.affiliation: Centre Hospitalier de l'Université de Montréal, University of Montreal, CHUM Pavillon R, 900 rue St Denis, Montreal, QC H2X 0A9, Canada.
authors.forename: Fred
authors.initials: F
authors.lastname: Saad
mesh_terms: D000736:Androstenes / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001549:Benzamides; D000077143:Docetaxel; D006801:Humans; D008297:Male; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000628:therapy*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000628:therapy; D043823:Taxoids / Q000627:therapeutic use
chemical_list: D000736:Androstenes; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D001549:Benzamides; D009570:Nitriles; D043823:Taxoids; D000077143:Docetaxel; D010669:Phenylthiohydantoin; C540278:enzalutamide; C089740:abiraterone